E-viri
Recenzirano
Odprti dostop
-
Pechoux, Cécile Le; Dhermain, Frederic; Besse, Benjamin
Lancet, 10/2016, Letnik: 388, Številka: 10055Journal Article
NSCLC management in 2016 still represents a real challenge because detectable brain metastases might be responsible for life-threatening symptoms and serious impairment of quality of life, possibly ameliorated with WBRT.7 Mulvenna and colleagues are to be congratulated for conducting this non-inferiority phase 3 trial assessing the omission of WBRT in patients with NSCLC and brain metastases.5 They chose quality-adjusted life-years (QALYs) as the primary outcome measure, and a group of 538 patients between 2007 and 2014 were randomly assigned to receive either WBRT (20 Gy in five daily fractions) and optimal supportive care, including dexamethasone (n=269), or optimal supportive care alone (n=269).
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.